Synthetic analog of human Insulin-Like Growth Factor-1 (IGF-1) Contains an arginine substitution at position 3 and an extended chain Research-grade Supplied as a lyophilized powder for laboratory research
For laboratory research use only. Not for human or veterinary consumption. SKU IG1.
In circulation, native IGF-1 is almost entirely bound by IGFBP-1 through IGFBP-6, leaving only a small free fraction available to the receptor. The Arg3 substitution weakens IGFBP binding while the N-terminal extension stabilizes the molecule, so Long R3 IGF-1 remains free far longer than native IGF-1. This property was first exploited in mammalian cell-culture research, where Long R3 IGF-1 became a standard supplement for sustaining the viability and productivity of cultured cells in reduced-serum media.
| Analog | 83-residue IGF-1 analog (Arg3 substitution + 13-residue N-terminal extension) |
| Molecular Weight | ~9111 g/mol |
| CAS Number | 946870-92-4 |
| Molecular Purity | See COA |
| Form | Lyophilized powder |
| Reconstitution | Bacteriostatic (BAC) water |
| Storage | Cool, dry, away from direct light |
| Quantity | 1mg per vial |
Studied for activation of the IGF-1 receptor and the downstream PI3K/Akt and MAPK cascades that govern cellular growth, proliferation, and survival.
A standard supplement in serum-free and reduced-serum mammalian cell culture, studied for its ability to sustain cell viability and product yield.
Investigated in skeletal-muscle and connective-tissue models for its role in protein-synthesis signaling and cellular hypertrophy and hyperplasia pathways.
Examined for cross-talk with insulin signaling and glucose-uptake pathways in metabolic research models.
For research use only. Not for human consumption.